In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sense Proteomic Ltd.

http://www.sensetherapeutic.com

Latest From Sense Proteomic Ltd.

Astex Cashes in with metaGen

Astex Technology's takeover of Schering AG spin-out metaGen Pharmaceuticals provides the Cambridge-based firm with more cash, a stronger relationship with a pharmaceutical partner, complementary technology assets, and, potentially, an improved preclinical pipeline. MetaGen investors inch closer to an exit by trading stakes in an early-stage, unfloatable company for a piece of a more mature, well-funded firm several steps closer to an IPO.

BioPharmaceutical Europe

Aliga: Are Mergers Between Biology and Chemistry Financeable?

The combination of Dutch firm Kiadis and Germany's Biofrontera, a technological fit, now needs to score with investors and provide the proposed new firm with enough cash to survive the biotech drought.

BioPharmaceutical Europe

Recent Dealmaking (02/2003)

Summarizing the month in European dealmaking.

M&A Makes Sense for Procognia

Procognia's acquisition of fellow Apax portfolio company Sense Proteomic could indicate a more proactive stance from VCs intent on consolidating their bets behind likely winners.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
UsernamePublicRestriction

Register